Anesteziologie a intenzivní medicína,
Journal Year:
2024,
Volume and Issue:
35(5), P. 301 - 304
Published: Dec. 19, 2024
Článek
přináší
výběr
zajímavých
událostí,
jakým
byl
Světový
den
bolesti,
zejména
v
návaznosti
Evropský
který
následuje
vždy
třetí
středu
říjnu.
Vliv
Evropské
unie
na
léčbu
bolesti
aktuálně
vydaném
dokumentu
zmiňuje
léky
proti
nicméně
je
zájem
EU
o
problematiku
chronické
zatím
spíše
okrajový.
IASP
mezinárodní
společnost
pro
vyhlásila
rok
2024
globálním
rokem
genderových
rozdílů
bolesti.
se
snažilo
osvětlit
toto
důležité
téma
průběhu
celosvětového
roku
a
dosáhnout
změny
přístupu
chápání
jak
u
lékařů,
tak
pacientů.
Jak
mohou
genderové
rozdíly
interagovat
s
mechanismy
způsobujícími
nebo
udržujícími
bolest,
posledních
letech
oblastí
rostoucího
zájmu.
Nové
poznatky
byly
publikovány
kanabidiolu,
bude
nutná
regulace
nejen
výroby,
ale
také
prodeje
reklamy.
Aktuálně
roce
vydán
první
pokyn
klinickou
praxi
Americké
akademie
pediatrů
(AAP),
přístupy
založené
důkazech
k
bezpečnému
předepisování
opioidů
akutní
bolest
pediatrické
populace
ambulantních
zařízeních.
Hlavním
cílem
pomoci
lékařům
pochopit,
kdy
být
opioidy
indikovány
léčbě
dětí
dospívajících
minimalizovat
rizika
užíváním
opioidů.
Pain,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 28, 2025
Abstract
Hyperalgesic
priming
is
a
model
system
that
has
been
widely
used
to
understand
plasticity
in
painful
stimulus–detecting
sensory
neurons,
called
nociceptors.
A
key
feature
of
this
following
priming,
stimuli
do
not
normally
cause
hyperalgesia
now
readily
provoke
state.
We
hypothesized
hyperalgesic
occurs
because
reorganization
translation
mRNA
To
test
hypothesis,
we
paclitaxel
treatment
as
the
stimulus
and
translating
ribosome
affinity
purification
measure
persistent
changes
Na
v
1.8+
Translating
sequencing
revealed
161
genes
with
persistently
altered
primed
Among
these
genes,
identified
Gpr88
upregulated
Metrn
downregulated.
provide
functional
evidence
for
related
model,
interleukin-6
model.
GPR88
agonist
injection
into
paw
had
no
effect
naive
mice
but
caused
mechanical
hypersensitivity
grimacing
responses
female
mice.
Systemic
Meteorin
completely
reversed
established
prostaglandin
E2
Our
work
demonstrates
nociceptor
translatomes
are
causative
producing
multiple
models
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 13, 2025
Summary
The
expression
of
hormonal
receptors
in
pain-processing
regions
complicates
understanding
the
effects
on
pain
mechanisms.
This
study
investigates
androgen
receptor
(AR)
involvement
sensitivity
and
sex
differences
perception.
Mechanical
thresholds
were
higher
normal
male
mice
compared
to
gonadectomized
(GDX)
female
mice,
correlating
with
serum
testosterone
levels.
In
dorsal
root
ganglia
(DRG),
AR
was
expressed
males
but
undetectable
GDX
females.
sensory
neuron-selective
conditional
knockout
(AR-cKO)
mechanical
significantly
lower
than
wild-type
males.
administration
propionate
or
dihydrotestosterone
raised
thresholds,
accompanied
by
increased
DRG.
effect
abolished
AR-cKO
females,
consistent
findings.
These
results
indicate
that
primary
neurons
are
critical
targets
signaling
regulating
sensitivity.
Frontiers in Pain Research,
Journal Year:
2025,
Volume and Issue:
6
Published: April 23, 2025
The
myelin
sheath
serves
both
as
insulator
and
metabolic
powerhouse
for
large-diameter
dorsal
root
ganglia
(DRG)
neurons—some
of
the
longest
cells
in
body—transmitting
sensory
impulses
from
periphery
to
spinal
cord.
When
is
damaged,
bioactive
fragments
basic
protein
(MBP)
are
released,
playing
a
pivotal
role
pathological
pain.
MBP-derived
peptides
(MBPd)
emerge
ubiquitous
yet
sex-specific
mediator
In
females,
MBPd
triggers
widespread
transcriptional
response
across
peripheral
nerve,
DRG,
cord,
leading
persistent,
treatment-resistant
tactile
allodynia—pain
normally
innocuous
touch.
contrast,
males
exhibit
only
localized
response,
confined
which
does
not
extend
DRG
or
cord
induce
sex
difference
driven
by
MBPd's
interaction
with
lipids
regulation
nuclear
receptor
transcription
factors,
including
estrogen
(ESR)
liver
X
(LXR)/retinoid
×
(RXR)
complex—key
regulators
lipid
cholesterol
metabolisms
mounting
sex-dependent
immunity.
By
unraveling
these
fundamental
mechanisms
remodeling,
this
work
opens
door
innovative,
non-addictive,
personalized
therapeutics
diagnostics
chronic
The Journal of Headache and Pain,
Journal Year:
2024,
Volume and Issue:
25(1)
Published: Oct. 15, 2024
Migraine
is
a
common
and
complex
neurological
disorder
that
has
high
impact
on
quality
of
life.
Recent
advances
with
drugs
target
the
neuropeptide
calcitonin
gene-related
peptide
(CGRP)
have
helped,
but
treatment
options
remain
insufficient.
CGRP
released
from
trigeminal
sensory
fibers
contributes
to
peripheral
sensitization,
perhaps
in
part
due
actions
immune
cells
trigeminovascular
system.
In
this
review,
we
will
discuss
potential
cannabinoid
targeting
as
an
innovative
therapeutic
for
migraine
treatment.
We
cover
endogenous
endocannabinoids,
plant-derived
phytocannabinoids
synthetically
derived
cannabinoids.
The
focus
be
six
types
known
express
multiple
receptors:
macrophages,
monocytes,
mast
cells,
dendritic
B
T
cells.
These
also
contain
receptors
such,
cannabinoids
might
potentially
modulate
efficacy
current
CGRP-targeting
drugs.
Unfortunately,
date
most
studies
relied
cell
cultures
only
single
preclinical
study
tested
model.
Encouragingly,
created
stable
chiral
analog
endocannabinoid
reduced
meningeal
degranulation.
Likewise,
clinical
trials
evaluating
safety
cannabinoid-based
therapies
patients
been
limited
are
encouraging.
Thus,
field
at
its
infancy
there
significant
gaps
our
understanding
migraine.
Future
research
exploring
interactions
between
could
lead
more
targeted
effective
treatments.
Neurobiology of Pain,
Journal Year:
2024,
Volume and Issue:
16, P. 100171 - 100171
Published: July 1, 2024
Migraine
affects
∼12
%
of
the
worldwide
population
and
is
more
prevalent
in
females,
which
suggests
a
role
sex
hormones
migraine
pathophysiology.
Most
studies
have
focused
on
estrogen
progesterone,
involvement
androgens
has
been
less
studied.
However,
due
to
recent
advances
androgen
interventions,
could
advance
new
androgen-based
treatments,
it
critical
better
understand
migraine.
Testosterone,
most
studied
androgen,
was
found
an
antinociceptive
effect
various
animal
human
pain
studies.
Thus,
also
protective
related
lower
severity
prevalence.
In
this
review,
we
discuss
examining
migraine-related
symptoms
models.
Additionally,
summarize
results
comparing
levels
between
patients
with
healthy
controls,
assessing
relationships
severity,
intervention
impact
testosterone
treatment
severity.
Many
limitations,
however,
suggest
that
may
minor
Still,
possible
are
involved
pathophysiology
sub-group
such
as
adolescents
or
postmenopausal
women.
We
potential
mechanisms
testosterone,
main
tested,
can
These
range
from
cellular
level
systems
behavior
include
sensory
neurons,
immune
vascular
systems,
stress
response,
brain
function,
mood.
Lastly,
future
directions
line
research.